The Incidence of Graves’ Hyperthyroidism Before and After COVID-19 Messenger RNA VaccinationMayumi Endo, Tracy S. Tylee, Mara Y. Roth et al.|Endocrine Practice|2023Cited by 10
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390Mayumi Endo, Irl B. Hirsch, Mara Y. Roth et al.|Diabetes Care|2023Cited by 5
Challenges in Diagnosing Cribriform Morular Thyroid CarcinomaJihong Qu, Tracy S. Tylee, Mara Y. Roth et al.|JCEM Case Reports|2025Cited by 4
Newly Developed Pathologic Grading System Predicts Clinical Outcomes in Medullary Thyroid CarcinomaMayumi Endo, Mara Y. Roth, Eric C. Huang|Clinical Thyroidology|2022Cited by 2
FRI462 Incidence Of Graves Hyperthyroidism Before And After The Implementation Of COVID-19 mRNA VaccinationJessica Oliveira Pinto, Mayumi Endo, Mara Y. Roth et al.|Journal of the Endocrine Society|2023Cited by 0